Export citation

Show simple item record

dc.contributor.authorWilliams, Kenneth R.*
dc.contributor.authorNairn, Angus C.*
dc.date.accessioned2021-02-11T20:51:18Z
dc.date.available2021-02-11T20:51:18Z
dc.date.issued2020*
dc.date.submitted2020-04-07 23:07:08*
dc.identifier44747*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/54529
dc.description.abstractThe Neuroproteomics Special Issue overviews the unique challenges that must be addressed to carry out meaningful MS/proteomics analyses on neural tissues and the technologies that are available to meet these challenges. The articles on Alzheimer’s disease, addiction, and schizophrenia illustrate how MS/proteomics technologies can be used to improve our ability to diagnose and understand the molecular basis for neurological diseases. Several articles will be of interest to investigators beyond the field of neurological disorders. The review on the discovery of biofluid biomarkers of neurodegenerative dementias will be of interest to investigators searching for other disease biomarkers. Similarly, the review on the role of neuroproteomics in elucidating mechanisms of drug addiction provides an overview of the utility of MS/proteomics approaches for addressing critical questions in addiction neuroscience that should be applicable to investigators involved in virtually any area of biomedical research. Likewise, the article on developing targeted MS approaches for quantifying postsynaptic density proteins will be useful for any investigator who wishes to design targeted assays for virtually any protein. Finally, the peroxidase-mediated proximity labeling technology, described in the article on mapping the proteome of the synaptic cleft, will be of interest to investigators interested in mapping other spatially restricted proteomes.*
dc.languageEnglish*
dc.subjectR5-920*
dc.subjectRC346-429*
dc.subject.othern/a*
dc.subject.otheranalgesia*
dc.subject.otherquantitative phosphoproteomics*
dc.subject.otherneurodegeneration*
dc.subject.otherneuron*
dc.subject.otherneuronal circuits*
dc.subject.othermating*
dc.subject.othersex-specific differences*
dc.subject.otherAMPA receptor complex*
dc.subject.otherparallel reaction monitoring*
dc.subject.othersplicing*
dc.subject.otherphosphorylation*
dc.subject.otherpeptidylglycine ?-amidating monooxygenase*
dc.subject.otherpherophorin*
dc.subject.otherAlzheimer’s disease*
dc.subject.otherneuroscience*
dc.subject.otheryohimbine*
dc.subject.othersynapses*
dc.subject.otheradolescence*
dc.subject.otherconformational antibody*
dc.subject.otheropioid receptors*
dc.subject.otherprotein interaction networks*
dc.subject.otherAlzheimer’s Disease*
dc.subject.othertransmembrane AMPA receptor regulatory protein*
dc.subject.otherneuroproteome*
dc.subject.otherethanol*
dc.subject.otherU1 snRNP*
dc.subject.othermass spectroscopy*
dc.subject.othermorphine*
dc.subject.otherprotein phosphatase-1*
dc.subject.otherneuroproteomics*
dc.subject.otheraxons*
dc.subject.otherreinstatement*
dc.subject.otherDIA*
dc.subject.othervoltage gated channels*
dc.subject.otherprohormone convertase*
dc.subject.otherpostsynaptic density*
dc.subject.otherneuroimmune*
dc.subject.otherdendrites*
dc.subject.othercarboxypeptidase*
dc.subject.otherGPCR signaling*
dc.subject.otherCaMKII*
dc.subject.otherFGF14*
dc.subject.otherSynCAM*
dc.subject.othernicotinic receptor*
dc.subject.othersynaptic plasticity*
dc.subject.otherplasma*
dc.subject.otherserum*
dc.subject.othercorticosterone*
dc.subject.otherdopamine*
dc.subject.otherReceptor-type tyrosine-protein phosphatase zeta*
dc.subject.otherPtprz1*
dc.subject.otherPRM*
dc.subject.othercell type*
dc.subject.otherschizophrenia*
dc.subject.otherlaser capture microdissection*
dc.subject.othersynapse specificity*
dc.subject.otherLC-MS/MS*
dc.subject.othermouse*
dc.subject.otherdrug abuse*
dc.subject.othersynaptic cleft*
dc.subject.otherstriatum*
dc.subject.otherCadm*
dc.subject.othercytokine*
dc.subject.otherspinophilin*
dc.subject.otherPSD*
dc.subject.othertrans-synaptic adhesion*
dc.subject.othernicotine*
dc.subject.otherproximity labeling*
dc.subject.otherbiomarkers*
dc.subject.otheraddiction*
dc.subject.otherPKA*
dc.subject.othersynapse*
dc.subject.otherproteome*
dc.subject.othersignal peptide*
dc.subject.otherventral tegmental area*
dc.subject.otherprotein aggregation*
dc.subject.othercerebrospinal fluid*
dc.subject.otherbioinformatics*
dc.subject.otherprogressive ratio*
dc.subject.otherinteractome*
dc.subject.othersubtilisin*
dc.subject.otheraffinity chromatography*
dc.subject.otherbasal ganglia*
dc.subject.othercocaine*
dc.subject.othertargeted proteomics*
dc.subject.otherpostsynaptic*
dc.subject.othermass spectrometry*
dc.subject.otherconnectome*
dc.subject.otherquantitative mass spectrometry*
dc.subject.otherbiotinylation*
dc.subject.otherproteomics*
dc.subject.otheramphetamine*
dc.subject.otherautism*
dc.subject.otherdata-independent acquisition*
dc.subject.otherexcitatory/inhibitory tone*
dc.subject.otherneuropeptidomics*
dc.subject.othermatrix metalloproteinase*
dc.subject.othercilia*
dc.subject.otherR-PTP-zeta*
dc.subject.othercognitive impairment*
dc.titleNeuroproteomics*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03928-107-7*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
virtual.oapen_relation_isPublishedBy.publisher_nameMDPI - Multidisciplinary Digital Publishing Institute
virtual.oapen_relation_isPublishedBy.publisher_websitewww.mdpi.com/books
oapen.relation.isbn9783039281077*
oapen.relation.isbn9783039281060*
oapen.pages318*
oapen.edition1st*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/